BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1231 related articles for article (PubMed ID: 15240783)

  • 21. Downregulation of SMG-1 in HPV-positive head and neck squamous cell carcinoma due to promoter hypermethylation correlates with improved survival.
    Gubanova E; Brown B; Ivanov SV; Helleday T; Mills GB; Yarbrough WG; Issaeva N
    Clin Cancer Res; 2012 Mar; 18(5):1257-67. PubMed ID: 22247495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of HPV-16 infection on hypopharyngeal squamous cell carcinoma and FaDu cells.
    Lu W; Feng L; Li P; Wang Y; Du Y; Chen X; Wu S; Zhao G; Lou W
    Oncol Rep; 2016 Jan; 35(1):99-106. PubMed ID: 26497405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarkers of HPV in head and neck squamous cell carcinoma.
    Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT
    Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus does not have a causal role in colorectal carcinogenesis.
    Lorenzon L; Mazzetta F; Pilozzi E; Uggeri G; Torrisi MR; Ferri M; Ziparo V; French D
    World J Gastroenterol; 2015 Jan; 21(1):342-50. PubMed ID: 25574110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 alterations and HPV infections are common in oral SCC: p53 gene mutations correlate with the absence of HPV 16-E6 DNA.
    Penhallow J; Steingrimsdottir H; Elamin F; Warnakulasuriya S; Farzaneh F; Johnson N; Tavassoli M
    Int J Oncol; 1998 Jan; 12(1):59-68. PubMed ID: 9454887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.
    Báez A; Cantor A; Fonseca S; Marcos-Martinez M; Mathews LA; Muro-Cacho CA; Muñoz-Antonia T
    Clin Cancer Res; 2005 May; 11(9):3191-7. PubMed ID: 15867212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
    Rampias T; Sasaki C; Weinberger P; Psyrri A
    J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential anticancer activities of arsenic trioxide on head and neck cancer cells with different human papillomavirus status.
    Du S; Liu K; Gao P; Li Z; Zheng J
    Life Sci; 2018 Nov; 212():182-193. PubMed ID: 30243648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line.
    Ragin CC; Reshmi SC; Gollin SM
    Int J Cancer; 2004 Jul; 110(5):701-9. PubMed ID: 15146560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
    Young RJ; Urban D; Angel C; Corry J; Lyons B; Vallance N; Kleid S; Iseli TA; Solomon B; Rischin D
    Br J Cancer; 2015 Mar; 112(6):1098-104. PubMed ID: 25688737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus detection in head and neck squamous cell carcinomas.
    Snow AN; Laudadio J
    Adv Anat Pathol; 2010 Nov; 17(6):394-403. PubMed ID: 20966645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest.
    Li C; Johnson DE
    Cell Cycle; 2013 Mar; 12(6):923-34. PubMed ID: 23421999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The presence of high-risk human papillomavirus (HPV) E6/E7 mRNA transcripts in a subset of sinonasal carcinomas is evidence of involvement of HPV in its etiopathogenesis.
    Laco J; Sieglová K; Vošmiková H; Dundr P; Němejcová K; Michálek J; Čelakovský P; Chrobok V; Mottl R; Mottlová A; Tuček L; Slezák R; Chmelařová M; Sirák I; Vošmik M; Ryška A
    Virchows Arch; 2015 Oct; 467(4):405-15. PubMed ID: 26229021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations of TP53 mutations, codon 72 polymorphism and human papillomavirus in head and neck squamous cell carcinoma patients.
    Shi Q; Xiao K; Wei W; Zhang BY; Chen C; Xu Y; Chen LN; Song YT; Ma X; Zhang NS; Dong XP
    Oncol Rep; 2013 Dec; 30(6):2811-9. PubMed ID: 24064928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways.
    Smeets SJ; van der Plas M; Schaaij-Visser TB; van Veen EA; van Meerloo J; Braakhuis BJ; Steenbergen RD; Brakenhoff RH
    Int J Cancer; 2011 Apr; 128(7):1596-605. PubMed ID: 20499310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention against head and neck cancer-containing HPV16 cell lines.
    Adhim Z; Otsuki N; Kitamoto J; Morishita N; Kawabata M; Shirakawa T; Nibu K
    Acta Otolaryngol; 2013 Jul; 133(7):761-71. PubMed ID: 23638950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of human papillomavirus prevalence and TP53 polymorphism in head and neck squamous cell carcinomas.
    Cortezzi SS; Provazzi PJ; Sobrinho JS; Mann-Prado JC; Reis PM; de Freitas SE; Filho JF; Fukuyama EE; Cordeiro JA; Cury PM; Maniglia JV; Villa LL; Tajara EH; Rahal P
    Cancer Genet Cytogenet; 2004 Apr; 150(1):44-9. PubMed ID: 15041222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy.
    Pogorzelski M; Ting S; Gauler TC; Breitenbuecher F; Vossebein I; Hoffarth S; Markowetz J; Lang S; Bergmann C; Brandau S; Jawad JA; Schmid KW; Schuler M; Kasper S
    Cell Death Dis; 2014 Feb; 5(2):e1091. PubMed ID: 24577089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population.
    Mitra S; Banerjee S; Misra C; Singh RK; Roy A; Sengupta A; Panda CK; Roychoudhury S
    J Clin Pathol; 2007 Sep; 60(9):1040-7. PubMed ID: 17079356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.